In the News

410 News Items found
Memorial Sloan Kettering medical oncologist Eileen O'Reilly
Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.
Scientific image showing spindle-shaped and round dormant metastatic cancer cells
New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.
DNA molecules wrapped around histones
Feature
Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Dr. Sohrab Shah
MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research.
Medical oncologist Emily Feld
Q&A
In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.
MSK radiation oncologist Kathryn Beal
In the Clinic
MSK’s Kathryn Beal presents new findings on combining radiation with immunotherapy for brain cancer.
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
bowl of edamame
Learn whether eating soy products causes cancer.
Young female cancer patient holding a tea cup
Q&A
Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer.
Dr. Alison Schram
The FDA has approved zenocutuzumab (Bizengri®) for adults with advanced, unresectable, or metastatic cholangiocarcinoma driven by a molecular change called an NRG1 gene fusion, based on a trial led by an MSK investigator.